Inventor
MISHRA RAMA K
US17 patents
⚠️ This page may combine multiple inventors who share the name “MISHRA RAMA K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NORTHWESTERN
7 patentsUS10435375B2Oct 8, 2019
CXCR4 chemokine receptor modulators
UNIV NORTHWESTERN4 citations72
US10093668B2Oct 9, 2018
Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
UNIV NORTHWESTERN5 citations68
US10851082B2Dec 1, 2020
Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)
UNIV NORTHWESTERN2 citations64
US11453640B2Sep 27, 2022
Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy
UNIV NORTHWESTERN0 citations57
US12564588B2Mar 3, 2026
HECT E3 ubiquitin liagase inhibitors and uses thereof
UNIV NORTHWESTERN0 citations50
US12152007B2Nov 26, 2024
Substituted heterocycles as c-MYC targeting agents
UNIV NORTHWESTERN0 citations45
US11142504B2Oct 12, 2021
Substituted heterocycles as c-MYC targeting agents
UNIV NORTHWESTERN0 citations45
ANGION BIOMEDICA CORP
5 patentsUS9597321B2Mar 21, 2017
Antifibrotic compounds and uses thereof
ANGION BIOMEDICA CORP3 citations72
US10414760B2Sep 17, 2019
Cytochrome P450 inhibitors and uses thereof
ANGION BIOMEDICA CORP3 citations71
US7648978B2Jan 19, 2010
Small molecule modulators of cytokine activity
ANGION BIOMEDICA CORP6 citations62
US11504359B2Nov 22, 2022
Antifibrotic compounds and uses thereof
ANGION BIOMEDICA CORP0 citations61
US10195184B2Feb 5, 2019
Antifibrotic compounds and uses thereof
ANGION BIOMEDICA CORP1 citations61